Joan B. Sabater
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Real-world evolution of therapeutic strategies and outcomes in acquired thrombotic thrombocytopenic purpura: a 14-year referral center experience.
Journal: Medicina clinica
Published: May 06, 2026
Optimising Meropenem and Piperacillin Dosing in Patients Undergoing Extracorporeal Membrane Oxygenation Without Renal Dysfunction (MEPIMEX).
Journal: Antibiotics (Basel, Switzerland)
Published: August 18, 2025
Long-Term Effects of a Stepwise, Multimodal, Non-Restrictive Antimicrobial Stewardship Programme for Reducing Broad-Spectrum Antibiotic Use in the ICU.
Journal: Antibiotics (Basel, Switzerland)
Published: December 19, 2023
External ventriculostomy-associated infection reduction after updating a care bundle.
Journal: Annals of clinical microbiology and antimicrobials
Published: September 23, 2022
Antimicrobial use and aetiology of bloodstream infections in critically ill patients during early stages of SARS-CoV-2 pandemic.
Journal: Infection prevention in practice
Published: April 11, 2022
Radio-Histological Correlation of Lung Features in Severe COVID-19 Through CT-Scan and Lung Ultrasound Evaluation.
Journal: Frontiers in medicine
Published: November 23, 2021
Lung Ultrasound Score to Predict Outcomes in COVID-19.
Journal: Respiratory care
Published: May 19, 2021
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit.
Journal: Frontiers in medicine
Published: May 17, 2021
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 29, 2020
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol.
Journal: Contemporary clinical trials communications
Published: June 07, 2020
Last Updated: 09/26/2026